BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3053574)

  • 1. Bactericidal mechanisms of ofloxacin.
    Lewin CS; Smith JT
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():1-8. PubMed ID: 3053574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of quinolones against staphylococci and relationship with their in vitro bactericidal activity.
    Ramón MS; Cantón E; Pemán J; Pastor A; Martínez JP
    Chemotherapy; 1999; 45(3):175-82. PubMed ID: 10224339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin.
    Lewin CS; Amyes SG
    J Med Microbiol; 1989 Nov; 30(3):227-31. PubMed ID: 2479750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bactericidal activity of ofloxacin against staphylococci.
    Lewin CS; Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):151-3. PubMed ID: 16312348
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci.
    Pascual A; Martínez-Martínez L; Perea EJ
    Chemotherapy; 1989; 35(1):17-22. PubMed ID: 2721289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
    Zemelman R; Vejar C; Bello H; Domínguez M; González G
    Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the 4-quinolones with other antibacterials.
    Lewin CS; Smith JT
    J Med Microbiol; 1989 Jul; 29(3):221-7. PubMed ID: 2664184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis.
    Lewin CS; Morrissey I; Smith JT
    J Pharm Pharmacol; 1991 Jul; 43(7):492-4. PubMed ID: 1682462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin.
    Morrissey I; Smith JT
    Microbios; 1994; 79(318):43-53. PubMed ID: 8078420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
    Parte AC; Smith JT
    Microbios; 1994; 80(322):31-9. PubMed ID: 7854197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation rates to 4-quinolone resistance.
    Smith JT
    Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin.
    Stein GE; Schooley S; McMillan J
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):261-5. PubMed ID: 9582586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL; Fuchs PC
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis.
    Parte AC; Smith JT
    Microbios; 1994; 79(319):87-95. PubMed ID: 7968664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
    Kowalski RP; Karenchak LM; Gordon YJ
    Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
    Barry AL; Fuchs PC
    J Antimicrob Chemother; 1991 Nov; 28(5):695-9. PubMed ID: 1663929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
    Tronel H; Voiriot P; Weber M; Dopff C; Dewachter P; Phelisse F; Dureux JB
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):578-81. PubMed ID: 2797882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.